Invega Sustenna Injection
Pricing Report NDC 50458-562-01

Current NADAC: $2,340.77880 per ML · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Invega Sustenna (NDC 50458-562-01) is $2340.77880 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Janssen Pharmaceuticals, Inc., this medication is distributed in a 1 SYRINGE in 1 KIT / .75 mL in 1 SYRINGE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2,340.77880
Per ML

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 SYRINGE in 1 KIT / .75 mL in 1 SYRINGE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1,142.55833 to $2,344.76593 per ML. Over this 13 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1,142.5583 - $2,344.7659
Market Volatility
105.22% Variance
Latest Trend
0.07%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $2340.77880 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $2342.46200 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $2344.27690 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $2344.76593 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 02, 2026 $2340.08100 MLC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 02, 2026 $2340.08100 MLC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 02, 2026 $2340.08100 MLC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Dec 17, 2025 $2285.23535 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $2283.22609 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $2284.17769 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $2283.23216 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 20, 2025 $2282.52193 MLC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026